nobiletin has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Q; Pan, M; Wang, L; Yang, J; Yang, Y | 1 |
| Bourland, TC; Miller, EG; Patil, BS; Peacock, JJ; Taylor, SE; Wright, JM | 1 |
2 other study(ies) available for nobiletin and Cancer of Mouth
| Article | Year |
|---|---|
Nobiletin selectively inhibits oral cancer cell growth by promoting apoptosis and DNA damage in vitro.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Flavones; Humans; Mouth Neoplasms; Reactive Oxygen Species | 2020 |
Inhibition of oral carcinogenesis by citrus flavonoids.
Topics: Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Citrus; Cricetinae; Flavanones; Flavones; Flavonoids; Hesperidin; Mouth Neoplasms; Random Allocation | 2008 |